Gore Excluder腹主动脉瘤腿支架治疗血透患者中心静脉狭窄或闭塞的结局
这项回顾性单臂队列研究纳入60例血液透析合并中心静脉狭窄或闭塞患者,2013年12月至2018年7月置入Gore Excluder腹主动脉瘤对侧腿支架。1年回路一期通畅率54.9%,靶部位一期通畅率88.3%,随访期间二期通畅率95%;合并病变者回路一期通畅障碍风险显著更高。
要点
- Gore Excluder对侧腿支架可用于血透患者中心静脉狭窄或闭塞。
- 1年回路一期通畅率54.9%,靶部位一期通畅率88.3%。
- 随访期间二期通畅率95%,合并病变者回路通畅障碍风险更高。
核心结论
- 使用支架移植物治疗血透患者中心静脉梗阻具有吸引力,因其锥形大直径设计和多种长度可选。
研究设计与样本
- 回顾性单臂队列研究,纳入60例血液透析合并中心静脉狭窄或闭塞患者,2013年12月至2018年7月置入Gore Excluder腹主动脉瘤对侧腿支架,术后3、6、12个月随访造影。
主要发现
- 1年回路一期通畅率为54.9%。
- 1年累积靶部位一期通畅率为88.3%。
- 随访期间二期通畅率为95%。
- 合并病变患者回路一期通畅障碍风险显著更高。
临床怎么用
- 对血透合并中心静脉狭窄或闭塞患者,可考虑使用Gore Excluder对侧腿支架移植物治疗。
- 合并病变患者回路一期通畅障碍风险更高,需关注随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Central venous occlusive disease is a critical complication in long-term hemodialysis patients with arteriovenous (AV) dialysis circuits. The purpose of this retrospective, single-arm cohort study was to evaluate the effectiveness of an abdominal aortic aneurysm (AAA) contralateral leg endoprosthesis to treat symptomatic central venous occlusive diseases in patients with chronic hemodialysis. METHODS: A prospective cohort study included 60 patients on hemodialysis presenting with central venous stenosis or occlusion, who were treated with a Gore Excluder AAA contralateral leg stent graft between December 2013 and July 2018. Follow-up angiography was obtained at 3, 6, and 12 months. The outcomes and duration of primary circuit and target site patency were measured from the time of the stent graft implantation to the first reintervention for AV circuit dysfunction and target site restenosis. Secondary patency was calculated from stent graft implantation to the point when AV access was no longer attainable. RESULTS: Circuit primary patency rate was 54.9% at 1 year of Gore Excluder AAA contralateral leg or iliac extender stent grafts, implanted in 60 hemodialysis patients with central vein occlusive disease. Cumulative target site primary patency rate was 88.3% at 1 year. Secondary patency rate was 95% during follow-up. Patients with concomitant lesions had a significantly higher risk of circuit primary patency dysfunction. CONCLUSIONS: Treatment of central vein obstructions in hemodialysis patients with stent grafts has been appealing owing to the tapered shape with a larger diameter and the availability of various lengths.
引用
- Chen YY, Wu CK, Lin CH, et al. Outcomes of the Gore Excluder abdominal aortic aneurysm leg endoprosthesis for treatment of central vein stenosis or occlusion in patients with chronic hemodialysis. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32067725. doi:10.1016/j.jvsv.2019.08.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。